Research ArticleClinical Studies
15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment
FRENS STEFFEN KRAUSE, BERNHARD WALTER, OLIVER JOSEF OTT, LOTHAR HÄBERLE, CHRISTIAN WEISS, CLAUS RÖDEL, BERND WULLICH and ROLF SAUER
Anticancer Research March 2011, 31 (3) 985-990;
FRENS STEFFEN KRAUSE
BERNHARD WALTER
OLIVER JOSEF OTT
LOTHAR HÄBERLE
CHRISTIAN WEISS
CLAUS RÖDEL
BERND WULLICH
In this issue
15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment
FRENS STEFFEN KRAUSE, BERNHARD WALTER, OLIVER JOSEF OTT, LOTHAR HÄBERLE, CHRISTIAN WEISS, CLAUS RÖDEL, BERND WULLICH, ROLF SAUER
Anticancer Research Mar 2011, 31 (3) 985-990;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)
- Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer
- The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
- Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy
- Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 Years